Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA’s Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer

Nov 16th, 2009
by admin.

MELVILLE, N.Y.–(HSMN NewsFeed)–OSI Pharmaceuticals, Inc. (NASDAQ: OSIP ) announced today that the Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva(R) (erlotinib) as a first-line maintenance therapy for patients with advanced non-s…
Biopharmaceuticals, Oncology, FDA
OSI Pharmaceuticals, Tarceva, erlotinib, Non-Small Cell Lung Cancer

OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA’s Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer

Posted in: Medical Sales Jobs.

← nContact Announces Initiation of Medical Trials for the Treatment of Atrial Fibrillation in Open-Chest Procedures
New Genomic Test for Coronary Artery Disease Now Available at The Heart and Vascular Center of Arizona →

0 Comments on “OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA’s Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer”

Leave a Comment